Two new point mutations at A2062 associated with resistance to 16-membered macrolide antibiotics in mutant strains of Mycoplasma hominis

被引:29
作者
Furneri, PM
Rappazzo, G
Musumarra, MP
Di Pietro, P
Catania, LS
Roccasalva, LS
机构
[1] Univ Catania, Dipartimento Sci Microbiol & Sci Ginecol, I-95124 Catania, Italy
[2] Univ Catania, Dipartimento Biol Anim, Catania, Italy
关键词
D O I
10.1128/AAC.45.10.2958-2960.2001
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
We describe two mutants of Mycoplasma hominis PG-21 which show resistance to 16-membered macrolides but susceptibility to lincosamides, obtained by in vitro exposure to increasing doses of josamycin. The 23S rRNA gene showed that each had a mutation (A2062G and A2062T) corresponding to nucleotide 2062 in Escherichia coli, which was associated with the acquired phenotype.
引用
收藏
页码:2958 / 2960
页数:3
相关论文
共 35 条
[31]   INVITRO SUSCEPTIBILITIES OF MYCOPLASMA-PNEUMONIAE, MYCOPLASMA-HOMINIS, AND UREAPLASMA-UREALYTICUM TO SPARFLOXACIN AND PD-127391 [J].
WAITES, KB ;
DUFFY, LB ;
SCHMID, T ;
CRABB, D ;
PATE, MS ;
CASSELL, GH .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1991, 35 (06) :1181-1185
[33]   Macrolide resistance [J].
Weisblum, B .
DRUG RESISTANCE UPDATES, 1998, 1 (01) :29-41
[34]   ERYTHROMYCIN RESISTANCE BY RIBOSOME MODIFICATION [J].
WEISBLUM, B .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (03) :577-585
[35]   ALLELE-SPECIFIC ENZYMATIC AMPLIFICATION OF BETA-GLOBIN GENOMIC DNA FOR DIAGNOSIS OF SICKLE-CELL ANEMIA [J].
WU, DY ;
UGOZZOLI, L ;
PAL, BK ;
WALLACE, RB .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (08) :2757-2760